Nutritional deficiency is associated with early mortality in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy

被引:0
|
作者
Corcoran, Anthony [1 ]
Uzzo, Robert G. [1 ]
Walton, John [1 ]
Piotrowski, Zachary [1 ]
Handorf, Elizabeth [1 ]
Chen, David [1 ]
Viterbo, Rosalia [1 ]
Greenberg, Richard E. [1 ]
Smaldone, Marc C. [1 ]
Kutikov, Alexander [1 ]
机构
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
关键词
D O I
10.1016/j.jamcollsurg.2013.07.345
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S147 / S147
页数:1
相关论文
共 50 条
  • [41] The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma
    Wood, CG
    UROLOGIC CLINICS OF NORTH AMERICA, 2003, 30 (03) : 581 - +
  • [43] Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology
    Kassouf, Wassim
    Sanchez-Ortiz, Ricardo
    Tamboli, Pheroze
    Tannir, Nizar
    Jonasch, Eric
    Merchant, Madhur M.
    Matin, Surena
    Swanson, David A.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2007, 178 (05): : 1896 - 1900
  • [44] Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?
    Mejean, Arnaud
    Ravaud, Alain
    Thezenas, Simon
    Chevreau, Christine
    Bensalah, Karim
    Geoffrois, Lionnel
    Thiery-Vuillemin, Antoine
    Cormier, Luc
    Lang, Herve
    Guy, Laurent
    Gravis, Gwenaelle
    Rolland, Frederic
    Linassier, Claude
    Lechevallier, Eric
    Oudard, Stephane
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Bernhard, Jean Christophe
    Colas, Sandra
    Albiges, Laurence
    Lebret, Thierry
    Treluyer, Jean-Marc
    Timsit, Marc-Olivier
    Escudier, Bernard
    EUROPEAN UROLOGY, 2021, 80 (04) : 417 - 424
  • [45] SURVIVAL ANALYSIS OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY WITH OR WITHOUT A NEOADJUVANT TYROSINE KINASE INHIBITOR
    Lo, Jing Zhi
    Sunaryo, Peter
    Paulucci, David
    Badani, Ketan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E867 - E867
  • [46] NLR as prognostic biomarker for metastatic renal cell carcinoma patients treated with cytoreductive nephrectomy
    Liu, Huanrui
    Li, Senlin
    Zhang, Fan
    He, Weiyang
    Gou, Xin
    Zhang, Xu
    Xie, Yongpeng
    BIOMARKERS IN MEDICINE, 2025,
  • [47] Systemic therapy after cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma
    Low, W. X. A.
    Gu, T.
    Lim, K. S. J.
    Yuen, S. P. J.
    Lee, L. S.
    Toh, C. K.
    Kanesvaran, R.
    Tan, H. S.
    Huang, H. H.
    Lau, K. O. W.
    BJU INTERNATIONAL, 2015, 115 : 12 - 13
  • [48] Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
    Aizer, Ayal A.
    Urun, Yuksel
    McKay, Rana R.
    Kibel, Adam S.
    Nguyen, Paul L.
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2014, 113 (5B) : E67 - E74
  • [49] Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines
    Larcher, Alessandro
    Fallara, Giuseppe
    Rosiello, Giuseppe
    Re, Chiara
    Baiamonte, Gianfranco
    Agnesi, Stefano
    Cignoli, Daniele
    Colandrea, Gianmarco
    Basile, Giuseppe
    Briganti, Alberto
    Salonia, Andrea
    Bertini, Roberto
    Montorsi, Francesco
    Capitanio, Umberto
    EUROPEAN UROLOGY, 2020, 78 (03) : 321 - 326
  • [50] IDENTIFYING PATIENTS WITH METASTATIC RENAL CELL CARCINOMA WHO WILL NOT BENEFIT FROM CYTOREDUCTIVE NEPHRECTOMY
    Culp, Stephen H.
    Abel, E. Jason
    Margulis, Vitaly
    Bill, Kate Lynn
    Tamboli, Pheroze
    Jonasch, Eric
    Matin, Surena F.
    Swanson, David A.
    Tannir, Nizar M.
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 498 - 498